F
AMAG

FolioMetrix’s AMAG Pharmaceuticals AMAG Stock Holding History

FolioMetrix’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$376K Hold
7,400
– – 0.16% 130
2015
Q1 		$404K Buy
+7,400
New +$353K 0.2% 100

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FolioMetrix's AMAG Position: Q2 2015 in Review

FolioMetrix held its AMAG Pharmaceuticals (AMAG) position steady in Q2 2015 at 7,400 shares worth $376K. The position accounts for 0.16% of the portfolio, ranked #130.

FolioMetrix first reported a position in AMAG in Q1 2015 and has held it in 2 quarters since. The position peaked at $404K in Q1 2015. 208 funds tracked by Wall St. Rank hold AMAG as of Q2 2015.

  • FolioMetrix held 7,400 shares of AMAG Pharmaceuticals worth $376K as of Q2 2015.
  • FolioMetrix left its AMAG Pharmaceuticals share count unchanged in Q2 2015.
  • AMAG Pharmaceuticals made up 0.16% of FolioMetrix's portfolio in Q2 2015, its #130 holding.
  • FolioMetrix first reported a position in AMAG Pharmaceuticals in Q1 2015 and has held it in 2 quarters since.
  • FolioMetrix's AMAG Pharmaceuticals position peaked at $404K in Q1 2015.
  • 208 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.